Medicinal products (non-steroidal anti-inflammatory compounds) for the treatment of chronic disorders - Scientific guideline

This guideline has been superseded by current ICH, EMA Pharmacokinetic, and disease specific guidance. No further updates to this guideline will be published.

This document provides guidance for the evaluation of non-steroidal anti-inflammatory medicinal products primarily in the symptomatic long-term treatment of such disorders as rheumatoid arthritis and osteoarthrosis and other disorders of joints, muscles and tendons.

Keywords: Non-steroidal anti-inflammatory drugs (NSAIDs), rheumatoid arthritis, osteoarthrosis, long-term treatment

Current effective version

Medicinal products (non-steroidal anti-inflammatory compounds) for the treatment of chronic disorders

Adopted Reference Number: 3CC17a Legal effective date: 01/08/2015